Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications

• Unité de recherche: INNOSUISSE
• Numéro de projet: 36334.1 IP-LS
• Titre du projet anglais: Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications

Description succincte (Allemand)

Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications

Description succincte (Anglais)

Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications

Résumé des résultats (Abstract) (Allemand)

The goal of this project is the assessment of the impact of the new rapid phenotypic antibiotic susceptibility test developed by Resistell on clinical decision making in bacteremia and sepsis. In addition, the method will be validated for two new indications, tuberculosis and chlamydia infections.